Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.
about
Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.MicroRNA-targeted therapeutics for lung cancer treatment.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1.
P2860
Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Assessment of the Protection o ...... Parkinson's Disease Rat Model.
@en
type
label
Assessment of the Protection o ...... Parkinson's Disease Rat Model.
@en
prefLabel
Assessment of the Protection o ...... Parkinson's Disease Rat Model.
@en
P2093
P2860
P356
P1476
Assessment of the Protection o ...... Parkinson's Disease Rat Model.
@en
P2093
Aurélie Doméné
Céline Mothes
Guylène Page
Johnny Vercouillie
Nuno Rodrigues
Sophie Sérrière
Sylvain Routier
Sylvie Bodard
P2860
P356
10.3389/FMED.2015.00061
P577
2015-09-02T00:00:00Z